Over the past 12 months, 0 insiders at MARINUS PHARMACEUTICALS, INC. filed 0 open-market SEC Form 4 transactions on MRNS: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 21, 25 | Elan EzicksonDirector | SELL | 1.6K | $0.54 | $864 |
| Jan 21, 25 | Marvin JohnsonDirector | SELL | 1.6K | $0.54 | $869 |
| Aug 14, 24 | Scott BraunsteinCHAIRMAN AND CEO | BUY | 5.9K | $1.10 | $7K |
| Aug 5, 24 | Scott BraunsteinCHAIRMAN AND CEO | SELL | 12.1K | $1.13 | $14K |
| Aug 5, 24 | Joseph HulihanCHIEF MEDICAL OFFICER | SELL | 4.8K | $1.13 | $5K |
| Aug 5, 24 | Martha E ManningSVP, GEN. COUNSEL & CORP. SEC. | SELL | 3.6K | $1.13 | $4K |
| Aug 5, 24 | Steven PfanstielCFO AND COO | SELL | 4.7K | $1.13 | $5K |
| Aug 5, 24 | Christina ShaferCHIEF COMMERCIAL OFFICER | SELL | 3.8K | $1.14 | $4K |
| Feb 20, 24 | Martha E ManningSVP, GEN. COUNSEL & CORP. SEC. | SELL | 1.9K | $9.57 | $18K |
| Feb 20, 24 | Christina ShaferCHIEF COMMERCIAL OFFICER | SELL | 2.2K | $9.56 | $21K |
| Feb 16, 24 | Scott BraunsteinCHAIRMAN AND CEO | SELL | 11.8K | $9.94 | $118K |
| Feb 16, 24 | Joseph HulihanCHIEF MEDICAL OFFICER | SELL | 2.8K | $9.98 | $28K |
| Feb 16, 24 | Steven PfanstielCFO AND COO | SELL | 3.1K | $9.97 | $31K |
| Aug 8, 23 | Scott BraunsteinCHAIRMAN AND CEO | SELL | 30 | $8.94 | $268 |
| Aug 8, 23 | Joseph HulihanCHIEF MEDICAL OFFICER | SELL | 13 | $8.93 | $116 |
| Aug 8, 23 | Martha E ManningSVP, GEN. COUNSEL & CORP. SEC. | SELL | 11 | $8.93 | $98 |
| Aug 8, 23 | Steven PfanstielCFO AND COO | SELL | 14 | $8.93 | $125 |
| Aug 8, 23 | Christina ShaferCHIEF COMMERCIAL OFFICER | SELL | 11 | $8.93 | $98 |
| Aug 7, 23 | Scott BraunsteinCHAIRMAN AND CEO | SELL | 6.4K | $9.55 | $61K |
| Aug 7, 23 | Joseph HulihanCHIEF MEDICAL OFFICER | SELL | 2.9K | $9.55 | $28K |
| Aug 7, 23 | Martha E ManningSVP, GEN. COUNSEL & CORP. SEC. | SELL | 2.2K | $9.54 | $21K |
| Aug 7, 23 | Steven PfanstielCFO AND COO | SELL | 2.8K | $9.54 | $27K |
| Aug 7, 23 | Christina ShaferCHIEF COMMERCIAL OFFICER | SELL | 2.4K | $9.52 | $23K |
| Feb 6, 23 | Charles AustinDirector | SELL | 1.1K | $6.49 | $7K |
| Feb 6, 23 | Elan EzicksonDirector | SELL | 750 | $6.56 | $5K |
| Feb 6, 23 | Fischer Seth H. Z.Director | SELL | 1.0K | $6.54 | $7K |
Over the past 12 months, insiders at MARINUS PHARMACEUTICALS, INC. filed 0 open-market purchases worth $0 and 0 sales worth $0 on MRNS, which makes them mixed over the period. The most recent Form 4 was filed on .
The largest recent open-market MRNS insider purchase in our data was $7K by Scott Braunstein, CHAIRMAN AND CEO, filed on Aug 14, 24.
0 different insiders at MARINUS PHARMACEUTICALS, INC. filed open-market SEC Form 4 transactions on MRNS over the last 12 months.
InsiderTape plots every MRNS insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every MARINUS PHARMACEUTICALS, INC. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →